GM

Ganesan Muralidharan

Active Director Director DIN 01121741
DIN 01121741 First appointment May 1995 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 1995
Shareholding value •••• Premium profile

About Ganesan Muralidharan

Data last updated:

Ganesan Muralidharan is a Director at Roots Pharma House Private Limited (since 1995). The company operates in Chemicals. Roots Pharma House Private Limited reported revenue of ₹1.47 Cr (FY 2025).

DIN 01121741
Primary Designation Director
Industry Chemicals
First Appointment 29 May 1995
Oldest Company Age 31 yrs
Largest company Roots Pharma House Private Limited · ₹1.47 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Roots Pharma House Private Limited U24231TN1995PTC031580
Director29 May 19951995₹1.47 Cr (FY 2025)Active

Board colleagues of Ganesan Muralidharan

Directorship timeline

Open interactive timeline →
Roots Pharma House Private Limited
Premium access

Shareholding and investment profile for Ganesan Muralidharan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ganesan Muralidharan

Ganesan Muralidharan currently holds 1 directorship: Roots Pharma House Private Limited (Director, since 29 May 1995, revenue ₹1.47 Cr (FY 2025)).

Ganesan Muralidharan was first appointed on 29 May 1995 as Director at Roots Pharma House Private Limited.

The current boards of Ganesan Muralidharan's companies include Pillipakkam Nattu Krishnakumar (Roots Pharma House Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available